Dr. Zhang’s research focus is on identifying novel drug outcomes from real-world data. Notable recent accomplishments of the Zhang Lab are the identification of telmisartan as a repurposable drug for Alzheimer's disease in African Americans and identifying relationships involving adverse drug events, drug combinations, and COVID-19 vaccines.

Research interests include drug repurposing, drug adherence, adverse drug event, and drug interactions. Specifically, developing statistical models to analyze real-world patient data to identify the aformentioned outcomes.

AnalytiXIN has supported Dr. Zhang’s lab financially and has given him opportunities to promote his research and make connections through AnalytiXIN faculty focused convenings.